Sign in

NCT06633991Completed

Expectancies in Migraine Patients

Expectancies About Positive Outcomes and Their Possible Potentiating Role of Standard Treatment in Migraine Patients

Source: ClinicalTrials.gov · Last updated 15 Oct 2024

Brief summary (registry, in English)

The aim of the present study is to examine whether the standard treatment prescribed to migraine patients is potentiated when coupled with a verbal instruction inducing more hope and optimism. In order to achieve the goal, outpatients with low-frequency episodic migraine diagnoses (\<8 attacks per month) and outpatients with chronic migraine diagnoses (\>15 attacks per month) will be screened and enrolled, thereafter they will be exposed to verbal instruction inducing more hope and optimism or to verbal instruction inducing hope and optimism together with standard treatment. We hypothesize that the group receiving verbal instruction inducing more hope and optimism would develop larger improvements in all outcome measures.

Status (registry)
Completed
Study type
Interventional
Enrollment
102 (actual)
First submitted
7 Oct 2024
Start date
1 Jan 2022
Primary completion date
31 Dec 2023
Lead sponsor
University of Florence
Diseases
Migraine
NCT number
NCT06633991

What you commit to

  • Study type: Interventional
  • Participants enrolled: 102
  • From 1 Jan 2022 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Standard treatment proposed different from topiramate, amitriptyline, valproate, β-blockers.
  • Inability to understand and want.

Who the study is looking for

  • Incident or prevalent diagnosis of low-frequency episodic migraine or chronic migraine according to ICHD criteria version 3 beta 2013.
  • Age of at least 18 years.
  • Signature of informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Fiammetta COSCI
Coordinator of this site? Confirm its status
FlorenceItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.